An active-comparator-controlled, open-label, parallel group study to evaluate the effect of survodutide on energy expenditure and fatty acid oxidation in subjects with obesity
-
Enrollment
This study is currently enrolling. -
Research Area
Translational Research -
Sponsor
Boehringer Ingelheim Pharmaceuticals
Enrollment Form
This study is currently enrolling.